UAE
Bahrain
Jordan
Kuwait
Oman
Qatar
Saudi ArabiaHealth News
A new guideline has provided an updated definition of severe asthma along with new recommendations for treating the condition
Date: Dec-16-2013Produced by a joint task force of the European Respiratory Society and the American Thoracic Society, the guideline is published online in the European Respiratory Journal.Although severe asthma is estimated to account for less than 10% of all asthmatics, these patients have the greatest burden and require a disproportionate amount of healthcare costs to be spent on treating their condition, which is harder to control.
A new guideline has provided an updated definition of severe asthma along with new recommendations for treating the condition
Date: Dec-16-2013Produced by a joint task force of the European Respiratory Society and the American Thoracic Society, the guideline is published online in the European Respiratory Journal.Although severe asthma is estimated to account for less than 10% of all asthmatics, these patients have the greatest burden and require a disproportionate amount of healthcare costs to be spent on treating their condition, which is harder to control.
FDA approves first generic versions of antidepressant drug Cymbalta
Date: Dec-16-2013The U.S. Food and Drug Administration has approved the first generic versions of Cymbalta (duloxetine delayed-release capsules), a prescription medicine used to treat depression and other conditions. Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Lupin Ltd., Sun Pharma Global FZE, Teva Pharmaceuticals USA, and Torrent Pharmaceuticals Ltd. have received FDA approval to market duloxetine in various strengths. "Health care professionals and consumers can be assured that these FDA-approved generic drugs have met our rigorous standards," said Kathleen Uhl, M.D.
FDA approves first generic versions of antidepressant drug Cymbalta
Date: Dec-16-2013The U.S. Food and Drug Administration has approved the first generic versions of Cymbalta (duloxetine delayed-release capsules), a prescription medicine used to treat depression and other conditions. Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Lupin Ltd., Sun Pharma Global FZE, Teva Pharmaceuticals USA, and Torrent Pharmaceuticals Ltd. have received FDA approval to market duloxetine in various strengths. "Health care professionals and consumers can be assured that these FDA-approved generic drugs have met our rigorous standards," said Kathleen Uhl, M.D.
FDA approves first generic versions of antidepressant drug Cymbalta
Date: Dec-16-2013The U.S. Food and Drug Administration has approved the first generic versions of Cymbalta (duloxetine delayed-release capsules), a prescription medicine used to treat depression and other conditions. Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Lupin Ltd., Sun Pharma Global FZE, Teva Pharmaceuticals USA, and Torrent Pharmaceuticals Ltd. have received FDA approval to market duloxetine in various strengths. "Health care professionals and consumers can be assured that these FDA-approved generic drugs have met our rigorous standards," said Kathleen Uhl, M.D.
Certain advanced breast cancer patients may benefit from surgery before other treatment, UPMC-advised study finds
Date: Dec-16-2013Patients newly diagnosed with advanced breast cancer and a solitary bone metastasis could benefit from surgery prior to other treatment, according to early results from a first-of-its kind clinical trial presented at the 2013 San Antonio Breast Cancer Symposium."In the U.S., approximately 5 percent of breast cancer patients are diagnosed with advanced disease when they first see their physician," said Atilla Soran, M.D., a breast surgical oncologist with Magee-Womens Hospital of UPMC and the study's lead investigator. "Around the world, that percentage can go as high as 10 percent.
New gene-editing system enables large-scale studies of gene function
Date: Dec-16-2013Since the completion of the Human Genome Project, which identified nearly 20,000 protein-coding genes, scientists have been trying to decipher the roles of those genes. A new approach developed at MIT, the Broad Institute, and the Whitehead Institute should speed up the process by allowing researchers to study the entire genome at once.The new system, known as CRISPR, allows researchers to permanently and selectively delete genes from a cell's DNA.
Researchers explore how mothers' blood sugar levels influence child fat
Date: Dec-16-2013Researchers from Manchester have begun a new study to determine whether blood sugar levels during pregnancy, lower than the level used to diagnose gestational diabetes, influences later levels of body fat in children and development of diabetes in mothers after giving birth. The team from The University of Manchester and Central Manchester NHS Foundation Trust are trying to trace mothers and children who took part in an earlier research project 12 years ago.
New gene-editing system enables large-scale studies of gene function
Date: Dec-16-2013Since the completion of the Human Genome Project, which identified nearly 20,000 protein-coding genes, scientists have been trying to decipher the roles of those genes. A new approach developed at MIT, the Broad Institute, and the Whitehead Institute should speed up the process by allowing researchers to study the entire genome at once.The new system, known as CRISPR, allows researchers to permanently and selectively delete genes from a cell's DNA.
New gene-editing system enables large-scale studies of gene function
Date: Dec-16-2013Since the completion of the Human Genome Project, which identified nearly 20,000 protein-coding genes, scientists have been trying to decipher the roles of those genes. A new approach developed at MIT, the Broad Institute, and the Whitehead Institute should speed up the process by allowing researchers to study the entire genome at once.The new system, known as CRISPR, allows researchers to permanently and selectively delete genes from a cell's DNA.
Stay Connected
